Inventor · name-matched record
PEI TAO
2 granted patents·7 pending applications·0 citations·filing 2020–2025
22Inventor score
Files withARROWHEAD PHARMACEUTICALS INC9
This identity is grouped by exact name match (no disambiguated inventor record was available for these filings) — it may combine same-named inventors.
Top patents by PatentIndex Score
9 records- 0185US2026043025A1RNAi Agents And Compositions for Inhibiting Expression of Apolipoprotein C-III (APOC3)ARROWHEAD PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0270US2026022381A1RNAi Agents for Inhibiting Expression of Complement Factor B (CFB), Pharmaceutical Compositions Thereof, and Methods of UseARROWHEAD PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0358US2026009037A1RNAi Agents for Inhibiting Expression of Mitochondrial Amidoxime Reducing Component 1 (MARC1), Pharmaceutical Compositions Thereof, and Methods of UseARROWHEAD PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0457US2026043029A1RNAi Agents for Inhibiting Expression of Thymic Stromal Lymphopoietin (TSLP), Compositions Thereof, and Methods of UseARROWHEAD PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0556US2026078375A1RNAi Agents for Inhibiting Influenza A Viral Gene Expression, Compositions Thereof, and Methods of UseARROWHEAD PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0655US2026071223A1Lipid conjugates for the delivery of therapeutic agents to adipose tissueARROWHEAD PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0753US2026021195A1Rnai agents for inhibiting expression of huntingtin (htt), compositions thereof, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0848US12582668B2Methods for the treatment of alpha-1 antitrypsin deficiency (AATD)ARROWHEAD PHARMACEUTICALS INC·Filed 2020·Granted Mar 24, 2026·0 cites·22 claims
- 0947US12551569B2RNAi agents for inhibiting expression of microtubule associated protein tau (MAPT), compositions thereof, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2025·Granted Feb 17, 2026·0 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when PEI TAO files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: exact name match across USPTO filings. How scoring works →